A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
A prenatal test developed by Columbia University researchers can determine if a fetus or embryo has the right number of chromosomes at a fraction of the time, cost of other genetic tests.
Twenty years ago, Columbia scientists created a way to make neurons in a dish, a discovery that has led to clinical trials of an experimental drug that may slow the progression of ALS.
Spontaneous errors in the earliest phase of cell division may explain why so many human embryos fail to develop normally, according to research from Columbia University.
Using EEG to identify covert consciousness in unresponsive brain-injured patients could help predict which ones may recover, find researchers at Columbia and NewYork-Presbyterian.
By analyzing thousands of genetic risk variants, a new algorithm developed by Columbia researchers may be able to predict your risk of developing chronic kidney disease decades before onset.